Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR2 | O43614 | 20/20 | 0.67 |
| ▸ | HCRTR1 | O43613 | 15/20 | 0.67 |
| ▸ | HTR1A | P08908 | 1/20 | 0.58 |
| ▸ | TSPO | P30536 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2131984 | 0.97 | HCRTR2 (0.71) | HCRTR2HCRTR1HTR1ATSPO | |
| SCHEMBL9949316 | 0.93 | HCRTR2 (0.64) | HCRTR2HCRTR1HTR1ATSPO | |
| SCHEMBL6422588 | 0.86 | HCRTR2 (0.75) | HCRTR2HCRTR1HTR1ATSPO | |
| SCHEMBL2132317 | 0.84 | HCRTR2 (0.70) | HCRTR2HCRTR1 | |
| SCHEMBL2133390 | 0.84 | HCRTR2 (0.75) | HCRTR2HCRTR1HTR1ATSPO | |
| SCHEMBL2133507 | 0.84 | HCRTR2 (0.73) | HCRTR2HCRTR1HTR1ATSPO | |
| SCHEMBL2605432 | 0.81 | HCRTR2 (0.57) | HCRTR2HCRTR1 | |
| SCHEMBL2132759 | 0.80 | HCRTR2 (0.77) | HCRTR2HCRTR1HTR1ATSPO | |
| SCHEMBL2027169 | 0.80 | HCRTR2 (1.00) | HCRTR2HCRTR1 | |
| SCHEMBL2134028 | 0.80 | HCRTR2 (0.71) | HCRTR2HCRTR1HTR1ATSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2632924-A1 | DIAZA-SPIRO[5.5]UNDECANES USEFUL AS OREXIN RECEPTOR ANTAGONISTS | Novartis AG (CH) | 2013-09-04 | — | — | EP | disclosed |
| WO-2012055888-A1 | DIAZA-SPIRO[5.5]UNDECANES USEFUL AS OREXIN RECEPTOR ANTAGONISTS | NOVARTIS AG (CH) | 2012-05-03 | — | — | WO | disclosed |